Sort
15,842 grants matching “pancreatic cancer”
A Fragment-Based Strategy for K-RAS Covalent Inhibitors
$462,460Samy Meroueh · University Of Illinois At Urbana-Champaign · R01 · FY2024 · CA
Fatty acid signaling in the pancreatic tumor microenvironment
$462,414Mara H. Sherman · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers
$462,242Stuart Duncan Ibsen · Oregon Health & Science University · R37 · FY2023 · CA
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
$462,168Chi V. Dang · Johns Hopkins University · R01 · FY2022 · CA
Mechanisms that Couple Chromatin Modifications to Transcription
$462,166Karen M Arndt · University Of Pittsburgh At Pittsburgh · R35 · FY2022 · GM
The role of wild-type KRAS in the context of tumor profession and metastasis
$462,118Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2017 · CA
AKT2 Function and Oncogenic Activity
$462,064Fox Chase Cancer Center · R01 · FY2004 · CA
University of Minnesota Clinical Center for the Study of Pancreatic Disease
$462,000Melena D. Bellin · University Of Minnesota · U01 · FY2020 · DK
Cancer invasion: reciprocity between the extracellular matrix and intrinsic ERK signaling
$461,852Michelle Christine Mendoza · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
Nanoscale Metal-organic Frameworks for Imaging and Therapy of Pancreatic Cancer
$461,760Wenbin Lin · Univ Of North Carolina Chapel Hill · U01 · FY2010 · CA
Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy
$461,562Matthew J Lazzara · University Of Virginia · U01 · FY2021 · CA
avb6-directed molecular imaging and therapy
$461,496Julie L Sutcliffe · University Of California At Davis · R01 · FY2016 · CA
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity
$461,446David G Denardo · Washington University · U01 · FY2025 · CA
Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy
$461,276Matthew J Lazzara · University Of Virginia · U01 · FY2020 · CA
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
$461,101Karen M Mann · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
ROS-targeted therapy for pancreatic cancer
$460,974Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
ROS-targeted therapy for pancreatic cancer
$460,974Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network
$460,956Evan L Fogel · Indiana University Indianapolis · U01 · FY2021 · DK
Radiotherapeutic Nanoseeds for Internal Radiation Therapy of Unresectable Solid Tumors
$460,887Yaowu Hao · University Of Texas Arlington · R15 · FY2016 · CA
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)
$460,814Jill C Fehrenbacher · Indiana University Indianapolis · R01 · FY2020 · CA
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)
$460,814Jill C Fehrenbacher · Indiana University Indianapolis · R01 · FY2021 · CA
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)
$460,814Jill C Fehrenbacher · Indiana University Indianapolis · R01 · FY2018 · CA
DYSBIOTIC MICROBIOME IN PANCREATITIS, DIABETES, AND PANCREATIC CANCER
$460,800William E Fisher · Baylor College Of Medicine · U01 · FY2024 · DK
Targeting Epigenomic Regulators at the Replication Fork in PDAC
$460,768Gwen Lomberk · Medical College Of Wisconsin · R01 · FY2025 · CA
VEGF and PDGF in angiogenesis and tumor progression
$460,615David A Cheresh · University Of California, San Diego · R37 · FY2011 · CA